AstraZeneca has sold its stake in Moderna for more than $1 billion -The Times
(Reuters) - AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company`s shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.
(Reuters) - AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company`s shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.
The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.
WATCH | Click on Zee Business Live TV Streaming Below:
AstraZeneca and Moderna did not immediately respond to requests for comment.
AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added.
Moderna, whose vaccine is cleared for emergency use against COVID-19 in the United States, said last week it was expecting sales of $18.4 billion from its coronavirus vaccine this year.
(Reporting by Maria Ponnezhath in Bengaluru; Editing by Jonathan Oatis and Peter Cooney)
The story has been taken from a news agency
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.